Group One Trading’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.3M | Buy |
136,282
+75,758
| +125% | +$588K | 0.04% | 2468 |
|
|
2025
Q4 | $472K | Buy |
60,524
+20,997
| +53% | +$152K | 0.01% | 3580 |
|
|
2025
Q3 | $300K | Buy |
+39,527
| New | +$329K | 0.01% | 4226 |
|
|
2025
Q2 | – | Hold |
0
| – | – | – | 8089 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 7720 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 7398 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 6758 |
|
|
2024
Q2 | – | Sell |
-46,044
| Closed | -$254K | – | 6831 |
|
|
2024
Q1 | $234K | Buy |
46,044
+14,616
| +47% | +$82.2K | 0.01% | 3423 |
|
|
2023
Q4 | $188K | Buy |
31,428
+19,537
| +164% | +$113K | 0.01% | 3920 |
|
|
2023
Q3 | $84.2K | Buy |
+11,891
| New | +$85.4K | ﹤0.01% | 4613 |
|
|
2023
Q2 | – | Sell |
-100,976
| Closed | -$810K | – | 7765 |
|
|
2023
Q1 | $842K | Sell |
100,976
-61,572
| -38% | -$593K | 0.04% | 2282 |
|
|
2022
Q4 | $1.87M | Buy |
162,548
+91,174
| +128% | +$1.14M | 0.06% | 1885 |
|
|
2022
Q3 | $899K | Sell |
71,374
-75,072
| -51% | -$966K | 0.03% | 2681 |
|
|
2022
Q2 | $1.55M | Buy |
+146,446
| New | +$1.51M | 0.04% | 2298 |
|
|
2022
Q1 | – | Sell |
-138,644
| Closed | -$2.22M | – | 8123 |
|
|
2021
Q4 | $1.92M | Buy |
138,644
+21,459
| +18% | +$284K | 0.04% | 2643 |
|
|
2021
Q3 | $1.68M | Buy |
+117,185
| New | +$1.85M | 0.04% | 2839 |
|
|
2021
Q2 | – | Sell |
-123,699
| Closed | -$1.68M | – | 8233 |
|
|
2021
Q1 | $1.26M | Sell |
123,699
-92,326
| -43% | -$952K | 0.03% | 2966 |
|
|
2020
Q4 | $1.61M | Buy |
216,025
+79,048
| +58% | +$408K | 0.05% | 2227 |
|
|
2020
Q3 | $471K | Buy |
136,977
+54,452
| +66% | +$233K | 0.02% | 2902 |
|
|
2020
Q2 | $393K | Buy |
+82,525
| New | +$330K | 0.02% | 2829 |
|
|
2020
Q1 | – | Sell |
-5,558
| Closed | -$15.3K | – | 5323 |
|
|
2019
Q4 | $19K | Buy |
5,558
+2,473
| +80% | +$6.22K | ﹤0.01% | 4378 |
|
|
2019
Q3 | $9K | Sell |
3,085
-101,205
| -97% | -$315K | ﹤0.01% | 4619 |
|
|
2019
Q2 | $395K | Buy |
104,290
+101,470
| +3,598% | +$611K | 0.04% | 2348 |
|
|
2019
Q1 | $23K | Buy |
+2,820
| New | +$24.1K | ﹤0.01% | 3954 |
|
|
2018
Q4 | – | Sell |
-3,879
| Closed | -$30.2K | – | 4918 |
|
|
2018
Q3 | $30K | Sell |
3,879
-3,404
| -47% | -$22.9K | ﹤0.01% | 4225 |
|
|
2018
Q2 | $42K | Buy |
7,283
+4,295
| +144% | +$23.6K | ﹤0.01% | 4041 |
|
|
2018
Q1 | $14K | Buy |
2,988
+1,594
| +114% | +$8.19K | ﹤0.01% | 4203 |
|
|
2017
Q4 | $7K | Sell |
1,394
-45,973
| -97% | -$223K | ﹤0.01% | 4470 |
|
|
2017
Q3 | $248K | Buy |
+47,367
| New | +$243K | 0.01% | 2611 |
|
|
2017
Q2 | – | Sell |
-95,908
| Closed | -$584K | – | 4781 |
|
|
2017
Q1 | $806K | Buy |
95,908
+14,732
| +18% | +$102K | 0.06% | 1491 |
|
|
2016
Q4 | $514K | Buy |
81,176
+77,460
| +2,084% | +$403K | 0.03% | 1756 |
|
|
2016
Q3 | $16K | Sell |
3,716
-9,181
| -71% | -$36.7K | ﹤0.01% | 3873 |
|
|
2016
Q2 | $37K | Buy |
12,897
+6,719
| +109% | +$20.9K | ﹤0.01% | 3477 |
|
|
2016
Q1 | $17K | Buy |
+6,178
| New | +$27.4K | ﹤0.01% | 3814 |
|
|
2015
Q4 | – | Sell |
-2,770
| Closed | -$27.5K | – | 4758 |
|
|
2015
Q3 | $32K | Buy |
+2,770
| New | +$37K | ﹤0.01% | 3799 |
|
|
2015
Q2 | – | Sell |
-9,735
| Closed | -$111K | – | 4860 |
|
|
2015
Q1 | $88K | Buy |
+9,735
| New | +$101K | 0.01% | 2977 |
|
|
2014
Q4 | – | Sell |
-15,064
| Closed | -$166K | – | 4901 |
|
|
2014
Q3 | $147K | Buy |
+15,064
| New | +$185K | 0.01% | 2644 |
|
|
2014
Q2 | – | Sell |
-6,599
| Closed | -$64.2K | – | 5184 |
|
|
2014
Q1 | $70K | Sell |
6,599
-64,526
| -91% | -$688K | 0.01% | 3373 |
|
|
2013
Q4 | $541K | Buy |
71,125
+36,320
| +104% | +$230K | 0.06% | 1607 |
|
|
2013
Q3 | $253K | Buy |
34,805
+19,686
| +130% | +$99.9K | 0.03% | 2174 |
|
|
2013
Q2 | $23K | Buy |
+15,119
| New | +$26.1K | ﹤0.01% | 3985 |
|
Other funds holding BCRX
RCM
DM
VPM
VCM
TCM
PA
VPC